Screening of young competitive athletes for the prevention of sudden cardiac death with a wireless electrocardiographic transmission device: a pilot study

BMC Research Notes

Abraham G Kocheril³  Mats A Selen²  Jae Hyung Cho¹ 

[1] Department of Hospital Medicine, Cleveland Clinic, Cleveland, OH, USA;Department of Physics, University of Illinois at Urbana-Champaign, Champaign, IL, USA;Department of Cardiology, College of Medicine, University of Illinois at Urbana-Champaign, 101 West University Avenue, Champaign 61820, IL, USA

关键词: Athletes;    Sudden cardiac death;    Screening;    Electrocardiogram;   

Others  :  1230894
DOI  :  10.1186/s13104-015-1311-9

 received in 2014-03-10, accepted in 2015-07-30,  发布年份 2015

【 摘 要 】

Background

The 12-lead electrocardiographic screening for the prevention of sudden cardiac death in young competitive athletes is not cost-effective and thus not routinely recommended. We investigate whether a less expensive wireless electrocardiographic transmission device can be used to screen for the prevention of sudden cardiac death in this population.

Methods

During pre-participation screening, twenty college football players underwent two electrocardiograms: a conventional 12-lead electrocardiogram and a wireless 9-lead electrocardiogram. We compared several electrocardiographic parameters (QRS duration, left ventricular hypertrophy using the Cornell voltage criteria and the Sokolow–Lyon criteria, ST deviation and corrected QT interval) to determine the correlation.

Results

The QRS duration, left ventricular hypertrophy using the Cornell voltage criteria and the Sokolow–Lyon criteria and corrected QT interval exhibited significant correlation between the two types of electrocardiograms (correlation coefficient 0.878, 0.630, 0.770 and 0.847, respectively with P values of 0.01, 0.003, 0.01 and 0.01, respectively). ST deviation in V1 was weakly correlated between the two types of electrocardiograms without statistical significance (correlation coefficient 0.360 with a P value of 0.119).

Conclusions

Our newly developed wireless 9-lead electrocardiogram demonstrated significant correlations with a conventional 12-lead electrocardiogram in terms of QRS duration, left ventricular hypertrophy and corrected QT interval.

【 授权许可】

   
2015 Cho et al.

【 图 表 】

Fig.1.

Fig.2.

Fig.3.

Fig.4.

Fig.5.

Fig.6.

Fig.7.

Fig.8.

【 参考文献 】

• [1]Maron BJ, Gohman TE, Aeppli D: Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes. J Am Coll Cardiol 1998, 32:1881-1884.
• [2]Maron BJ: Sudden death in young athletes. N Engl J Med 2003, 349:1064-1075.
• [3]Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G: Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 2003, 42:1959-1963.
• [4]Corrado D, Pelliccia A, Bjornstad HH, Vanhees L, Biffi A, Borjesson M, et al.: Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus statement of the study group of sport cardiology of the working group of cardiac rehabilitation and exercise physiology and the working group of myocardial and pericardial diseases of the European Society of Cardiology. Eur Heart J 2005, 26:516-524.
• [5]Maron BJ, Thompson PD, Ackerman MJ, Balady G, Berger S, Cohen D, et al.: Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on nutrition, physical activity, and metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2007, 115:1643-1655.
• [6]Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G: Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006, 296:1593-1601.
• [7]Halkin A, Steinvil A, Rosso R, Adler A, Rozovski U, Viskin S: Preventing sudden death of athletes with electrocardiographic screening: what is the absolute benefit and how much will it cost? J Am Coll Cardiol 2012, 60:2271-2276.